Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronen Levy

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Scientific Reports|March 10, 2019
Author Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cellsNouar Qutob, Ikuo Masuho, Michal Alon, et al.
Scientific Reports|January 14, 2018
RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cellsNouar Qutob, Ikuo Masuho, Michal Alon, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Temporal genomic analysis of melanoma rejection identifies regulators of tumor immune evasionSapir Cohen Shvefel, Joy A Pai, Yingying Cao, et al.
Cell|September 17, 2019
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in MelanomaYochai Wolf, Osnat Bartok, Sushant Patkar, et al.
Cell Reports. Medicine|December 17, 2025
Lymphodepleting chemotherapy potentiates neoantigen-directed T cell therapy by enhancing antigen presentationShira Sagie, Tomer Babu, Chen Weller, et al.
Nature|December 17, 2020
Anti-tumour immunity induces aberrant peptide presentation in melanomaOsnat Bartok, Abhijeet Pataskar, Remco Nagel, et al.
Cancer Discovery|September 14, 2018
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in MelanomaShelly Kalaora, Yochai Wolf, Tali Feferman, et al.
Cell|August 14, 2018
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical SignaturesJoo Sang Lee, Lital Adler, Hiren Karathia, et al.
The Journal of Clinical Investigation|October 15, 2021
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanomaAviyah Peri, Erez Greenstein, Michal Alon, et al.
Immunity|April 9, 2026
Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidomeRoberto Vendramin, Hongchang Fu, Shanila Fernandez Patel, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Scientific Reports|March 10, 2019
Author Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cellsNouar Qutob, Ikuo Masuho, Michal Alon, et al.
Scientific Reports|January 14, 2018
RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cellsNouar Qutob, Ikuo Masuho, Michal Alon, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Temporal genomic analysis of melanoma rejection identifies regulators of tumor immune evasionSapir Cohen Shvefel, Joy A Pai, Yingying Cao, et al.
Cell|September 17, 2019
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in MelanomaYochai Wolf, Osnat Bartok, Sushant Patkar, et al.
Cell Reports. Medicine|December 17, 2025
Lymphodepleting chemotherapy potentiates neoantigen-directed T cell therapy by enhancing antigen presentationShira Sagie, Tomer Babu, Chen Weller, et al.
Nature|December 17, 2020
Anti-tumour immunity induces aberrant peptide presentation in melanomaOsnat Bartok, Abhijeet Pataskar, Remco Nagel, et al.
Cancer Discovery|September 14, 2018
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in MelanomaShelly Kalaora, Yochai Wolf, Tali Feferman, et al.
Cell|August 14, 2018
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical SignaturesJoo Sang Lee, Lital Adler, Hiren Karathia, et al.
The Journal of Clinical Investigation|October 15, 2021
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanomaAviyah Peri, Erez Greenstein, Michal Alon, et al.
Immunity|April 9, 2026
Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidomeRoberto Vendramin, Hongchang Fu, Shanila Fernandez Patel, et al.
Pageof 3